| 0.95 -0.005 (-0.53%) | 09-13 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.19 | 1-year : | 1.28 |
| Resists | First : | 1.01 | Second : | 1.1 |
| Pivot price | 0.99 |
|||
| Supports | First : | 0.88 | Second : | 0.74 |
| MAs | MA(5) : | 0.96 |
MA(20) : | 0.98 |
| MA(100) : | 0.81  |
MA(250) : | 0.76 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 21.7 |
D(3) : | 28.9 |
| RSI | RSI(14): 47 |
|||
| 52-week | High : | 1.1 | Low : | 0.51 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ MLSS ] has closed above bottom band by 20.8%. Bollinger Bands are 18.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.98 - 0.99 | 0.99 - 0.99 |
| Low: | 0.92 - 0.93 | 0.93 - 0.94 |
| Close: | 0.94 - 0.95 | 0.95 - 0.96 |
Milestone Scientific Inc. designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. The company also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances; and disposable injection handpiece for the tactile control during the injection. In addition, it provides CompuFlo Epidural, a computer controlled anesthesia system for use in various medical applications. Further, the company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Livingston, New Jersey.
Sat, 07 Sep 2024
Milestone Scientific (NYSE:MLSS) Now Covered by StockNews.com - MarketBeat
Fri, 30 Aug 2024
StockNews.com Initiates Coverage on Milestone Scientific (NYSE:MLSS) - MarketBeat
Sun, 18 Aug 2024
Milestone Scientific (NYSE:MLSS) Releases Earnings Results, Misses Estimates By $0.01 EPS - MarketBeat
Fri, 16 Aug 2024
Milestone Scientific Inc. (AMEX:MLSS) Q2 2024 Earnings Call Transcript - Insider Monkey
Thu, 15 Aug 2024
Milestone Scientific Provides Business Update and Reports Financial Results for the Second Quarter of 2024 - StockTitan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
AMEX
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 71 (M) |
| Shares Float | 56 (M) |
| Held by Insiders | 15.9 (%) |
| Held by Institutions | 6.3 (%) |
| Shares Short | 460 (K) |
| Shares Short P.Month | 565 (K) |
| EPS | -0.1 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.1 |
| Profit Margin | -71.1 % |
| Operating Margin | -73.2 % |
| Return on Assets (ttm) | -34.6 % |
| Return on Equity (ttm) | -77.2 % |
| Qtrly Rev. Growth | -7.1 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0.13 |
| EBITDA (p.s.) | -0.1 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -5 (M) |
| Levered Free Cash Flow | -3 (M) |
| PE Ratio | -10.56 |
| PEG Ratio | 0 |
| Price to Book value | 9.5 |
| Price to Sales | 6.88 |
| Price to Cash Flow | -13.06 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|